KREHER NERISSA
Insider CIK 1741850 · RZLT Director · AVRO Chief Medical Officer · TRDA Chief Medical Officer · XERS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-07-01 | 2026-07-02 | 37,910 | $8.00 | $303.3K | 37,910 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-07-01 | 2026-07-02 | 33,582 | — | $0 | 33,582 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RZLT Rezolute, Inc. | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 58,576 | SEC↗ |
| RZLT Rezolute, Inc. | P Buy | 2025-06-13 | 2025-06-23 | 3,076 | $3.25 | $10.0K | 37,576 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2025-06-10 | 2025-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RZLT Rezolute, Inc. | A Award | 2025-06-10 | 2025-06-13 | 9,000 | — | $0 | 34,500 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2025-02-16 | 2025-02-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RZLT Rezolute, Inc. | A Award | 2025-02-16 | 2025-02-19 | 25,500 | — | $0 | 25,500 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2024-01-23 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-09-06 | 2023-09-06 | 871 | $13.46 | $11.7K | 40,058 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-09-06 | 2023-09-06 | 21 | $14.00 | $294 | 40,037 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 401 | $14.46 | $5.8K | 40,929 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2023-09-01 | 2023-09-06 | 21,500 | — | $0 | 21,500 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award | 2023-09-01 | 2023-09-06 | 14,200 | — | $0 | 41,330 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2023-08-04 | 2023-08-04 | 6,898 | — | $0 | 88,012 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-08-04 | 2023-08-04 | 6,898 | $14.14 | $97.5K | 27,130 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2023-08-04 | 2023-08-04 | 6,898 | $2.10 | $14.5K | 34,028 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 9,464 | — | $0 | 94,910 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-08-03 | 2023-08-04 | 9,464 | $14.74 | $139.5K | 27,130 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2023-08-03 | 2023-08-04 | 9,464 | $2.10 | $19.9K | 36,594 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 10,348 | — | $0 | 104,374 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 1,000 | $16.01 | $16.0K | 27,198 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 9,280 | $15.09 | $140.0K | 28,198 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2023-08-02 | 2023-08-04 | 10,348 | $2.10 | $21.7K | 37,478 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 68 | $16.82 | $1.1K | 27,130 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | F Tax w/h | 2023-03-02 | 2023-03-03 | 945 | $11.60 | $11.0K | 42,971 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 1,477 | $10.49 | $15.5K | 41,494 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 164 | $11.22 | $1.8K | 41,330 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-04-19 | 21,500 | — | $0 | 21,500 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award | 2023-03-01 | 2023-04-19 | 14,200 | — | $0 | 27,130 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 43,000 | — | $0 | 43,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-03 | 28,400 | — | $0 | 43,916 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-12-30 | 2023-01-03 | 5,200 | $13.45 | $69.9K | 15,516 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-10-26 | 2022-10-27 | 4,960 | — | $0 | 114,722 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-10-26 | 2022-10-27 | 643 | $21.21 | $13.6K | 25,033 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-10-26 | 2022-10-27 | 4,960 | $2.10 | $10.4K | 25,676 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-10-26 | 2022-10-27 | 4,317 | $22.01 | $95.0K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-10-25 | 2022-10-27 | 8,040 | — | $0 | 119,682 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-27 | 4,942 | $20.53 | $101.5K | 23,814 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-10-25 | 2022-10-27 | 8,040 | $2.10 | $16.9K | 28,756 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-27 | 2,998 | $21.42 | $64.2K | 20,816 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-27 | 100 | $22.13 | $2.2K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-28 | 2022-09-28 | 3,122 | — | $0 | 16,032 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-28 | 2022-09-28 | 3,122 | $2.10 | $6.6K | 23,838 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-28 | 2022-09-28 | 3,122 | $15.25 | $47.6K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-27 | 2022-09-28 | 2,403 | — | $0 | 19,154 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-27 | 2022-09-28 | 2,403 | $15.31 | $36.8K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-27 | 2022-09-28 | 2,403 | $2.10 | $5.0K | 23,119 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-26 | 2022-09-28 | 3,068 | — | $0 | 21,557 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 300 | $16.33 | $4.9K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 2,768 | $15.22 | $42.1K | 21,016 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-26 | 2022-09-28 | 3,068 | $2.10 | $6.4K | 23,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-23 | 2022-09-23 | 939 | — | $0 | 24,625 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-23 | 2022-09-23 | 939 | $2.10 | $2.0K | 21,655 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-23 | 2022-09-23 | 939 | $15.09 | $14.2K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-21 | 2022-09-23 | 3,341 | — | $0 | 25,564 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-21 | 2022-09-23 | 3,341 | $15.08 | $50.4K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-21 | 2022-09-23 | 3,341 | $2.10 | $7.0K | 24,057 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-15 | 2022-09-19 | 106 | — | $0 | 28,905 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-15 | 2022-09-19 | 106 | $15.01 | $1.6K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-15 | 2022-09-19 | 106 | $2.10 | $223 | 20,822 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-09 | 2022-09-12 | 800 | — | $0 | 29,011 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-09 | 2022-09-12 | 800 | $2.10 | $1.7K | 21,516 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-09 | 2022-09-12 | 800 | $15.07 | $12.1K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise deriv | 2022-09-08 | 2022-09-12 | 1,221 | — | $0 | 29,811 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2022-09-08 | 2022-09-12 | 1,221 | $2.10 | $2.6K | 21,937 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2022-09-08 | 2022-09-12 | 1,221 | $15.13 | $18.5K | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award | 2022-09-01 | 2022-09-06 | 5,172 | — | $0 | 20,716 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 31,032 | — | $0 | 31,032 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 62,063 | — | $0 | 62,063 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-03 | 10,344 | — | $0 | 15,544 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | X Exercise deriv | 2021-12-29 | 2021-12-29 | 5,200 | — | $0 | 142,722 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | M Exercise | 2021-12-29 | 2021-12-29 | 5,200 | $2.10 | $10.9K | 5,200 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 72,012 | — | $0 | 72,012 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2021-06-14 | 2021-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AVRO AVROBIO, Inc. | M Exercise deriv | 2018-10-08 | 2018-10-10 | 2,942 | — | $0 | 24,629 | SEC↗ |
| AVRO AVROBIO, Inc. | M Exercise | 2018-10-08 | 2018-10-10 | 2,942 | $0.91 | $2.7K | 2,942 | SEC↗ |